Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $233.50 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $110.67 | 2 | $0 (2022) |
| ABBVIE INC. | $78.69 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.76 | 1 | $0 (2018) |
| Novo Nordisk Inc | $15.42 | 1 | $0 (2019) |
| Allergan Inc. | $12.96 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.09 | 1 | ABBVIE INC. ($23.09) |
| 2023 | $42.60 | 2 | AbbVie Inc. ($42.60) |
| 2022 | $27.90 | 2 | SANOFI-AVENTIS U.S. LLC ($14.90) |
| 2019 | $15.42 | 1 | Novo Nordisk Inc ($15.42) |
| 2018 | $15.76 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($15.76) |
| 2017 | $108.73 | 2 | SANOFI-AVENTIS U.S. LLC ($95.77) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: NEUROSCIENCE | ||||||
| 05/12/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 01/28/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Diabetes | ||||||
| 02/12/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: DIABETES | ||||||
| 02/09/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $95.77 | General |
| Category: DIABETES | ||||||
| 02/02/2017 | Allergan Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,346 | 2,091 | $305,931 | $106,310 |
| 2022 | 22 | 1,223 | 1,712 | $236,404 | $83,087 |
| 2021 | 22 | 1,461 | 2,148 | $258,561 | $95,590 |
| 2020 | 21 | 1,351 | 1,930 | $208,090 | $70,460 |
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 286 | 533 | $129,224 | $38,323 | 29.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 159 | 159 | $47,541 | $18,826 | 39.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 59 | 220 | $31,680 | $9,972 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 93 | 116 | $19,899 | $5,695 | 28.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $7,840 | $5,634 | 71.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 56 | 56 | $5,096 | $3,953 | 77.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 22 | 97 | $11,839 | $3,458 | 29.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 27 | $9,161 | $3,080 | 33.6% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 22 | 22 | $6,424 | $3,003 | 46.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 219 | 313 | $2,634 | $2,481 | 94.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $5,730 | $1,994 | 34.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 64 | 64 | $3,700 | $1,800 | 48.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $4,213 | $1,537 | 36.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 21 | 33 | $3,597 | $1,104 | 30.7% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 43 | 50 | $3,600 | $959.28 | 26.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 14 | 25 | $2,800 | $878.53 | 31.4% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 22 | 22 | $1,826 | $799.68 | 43.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $1,112 | $571.40 | 51.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 52 | 62 | $1,240 | $458.12 | 36.9% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 16 | 57 | $1,653 | $435.03 | 26.3% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 25 | 25 | $1,075 | $324.72 | 30.2% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 15 | 15 | $1,230 | $312.02 | 25.4% |
| 85610 | Blood test, clotting time | Office | 2023 | 16 | 65 | $715.00 | $273.00 | 38.2% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 15 | 17 | $986.00 | $187.34 | 19.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 19 | 20 | $900.00 | $168.80 | 18.8% |
About Dr. Debra Sixta, M.D
Dr. Debra Sixta, M.D is a Family Medicine healthcare provider based in Altoona, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265492458.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Debra Sixta, M.D has received a total of $233.50 in payments from pharmaceutical and medical device companies, with $23.09 received in 2024. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($233.50).
As a Medicare-enrolled provider, Sixta has provided services to 5,381 Medicare beneficiaries, totaling 7,881 services with total Medicare billing of $355,448. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Altoona, IA
- Active Since 03/23/2006
- Last Updated 08/09/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1265492458
Products in Payments
- SOLIQUA (Drug) $95.77
- QULIPTA (Drug) $42.64
- UBRELVY (Drug) $36.05
- JARDIANCE (Drug) $15.76
- Tresiba (Drug) $15.42
- SOLIQUA 100/33 (Biological) $14.90
- LINZESS (Drug) $12.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Altoona
David Lemchak, Do, DO
Family Medicine — Payments: $8,660
Mr. Elias Rifkah, Md, MD
Family Medicine — Payments: $8,131
Amanda Cattoi-Seifert, Md, MD
Family Medicine — Payments: $6,899
Jeffrey Armstrong, Md, MD
Family Medicine — Payments: $2,402
Dr. John Reinhardt, D.o, D.O
Family Medicine — Payments: $2,067
Sarah Reinhardt, D.o, D.O
Family Medicine — Payments: $1,812